Drug intelligence / Profile preview

pirlimycin

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intramammary
01

Overview

Pirlimycin is a semi-synthetic antibiotic of the lincosamide class, structurally related to clindamycin but with a six-membered ring replacing clindamycin’s five-membered ring. It is primarily used in veterinary medicine for the treatment of clinical and subclinical mastitis in lactating dairy cattle, especially those infections caused by Gram-positive bacteria such as *Staphylococcus aureus* and various *Streptococcus* species. Pirlimycin acts as a bacteriostatic agent by binding to the 50S ribosomal subunit (specifically interacting with 23S rRNA), thereby inhibiting bacterial protein synthesis through interference with peptidyl transferase activity and aminoacyl-tRNA binding. The drug is administered intramammarily, typically as its hydrochloride salt under the brand name Pirsue[1][2][3][4][5][6][8].

Brand names
Pirsue
Other names
pirlimycin hydrochloridepirlimycin HCl
02

Targets

PTC (50S ribosomal peptidyl transferase center)

Beyond the preview

Go deeper on pirlimycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pirlimycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call